Funding and Job Opportunities

Home Research For Researchers Research Digest Funding and Job Opportunities

Current relevant funding and job opportunities for pancreatic cancer researchers.

Funding opportunities:

 

 

2019 Pancreatic Cancer Action Network Catalyst Grant
Application deadline: Dec. 7, 2018
Award is $500,000 over three years. Supports junior faculty to conduct pancreatic cancer research and establish successful career paths in the field. Proposed research may be basic, translational, clinical or epidemiological in nature and must have direct applicability and relevance to pancreatic cancer.

2019 Pancreatic Cancer Action Network Translational Research Grant
Application deadline: Dec. 21, 2018
Award is $500,000 over two years. Supports an independent investigator conducting high priority pancreatic cancer research that is poised for important translational next steps to help move scientific discovery to application in patients. Proposed research should aim to identify novel targets and approaches to the treatment of pancreatic cancer or understand and circumvent treatment resistance. Please see FAQs or RFA for research areas of interest.

The Mark Foundation ASPIRE Awards
Project concept letters deadlines: January 7, 2019
The Mark Foundation for Cancer Research ASPIRE Awards (Accelerating Scientific Platforms and Innovative REsearch) are designed to enable innovative approaches to solving high-impact problems in cancer research that tend to fall outside the scope of other funding opportunities.

National Cancer Institute Funding Opportunities
NCI funding opportunities are listed by type, research topic or special initiatives.

American Cancer Society Funding Opportunities
The American Cancer Society focuses its funding on investigator-initiated, peer-reviewed proposals. This intellectual freedom encourages discovery in areas that scientists believe are most likely to solve the problems of cancer. The American Cancer Society also offers grants that support the clinical and/or research training of health professionals (nurses, physicians, and social workers).

Cancer MoonshotSM – Funding Opportunities
The funding opportunity announcements (FOAs) listed on this page highlight research initiatives that align with the efforts of the Cancer Moonshot. They may be supported with existing funds or with the 21st Century Cures funding.

 

 

Job opportunities:

Postdoctoral Position: Fox Chase Cancer Center
There is an opening for a motivated Postdoctoral Fellow in the research laboratory of Paul Campbell, PhD, in the Cancer Biology Program at Fox Chase Cancer Center (FCCC) in Philadelphia, PA. The lab focuses on gastrointestinal cancers, particularly pancreatic cancer, and the microenvironment signaling that drives cancer progression. They are interested in basic and translational science approaches that ultimately lead to improved therapeutics. The lab resides in the newly-formed Marvin and Concetta Greenberg Pancreatic Cancer Institute within FCCC.

The ideal candidate will have an interest in identifying novel mechanisms that promote the development of cancer from early lesions through to metastatic disease, using fundamental mechanisms discovered in model systems as a starting point. Familiarity with methods for manipulating gene expression and signaling in mammalian cultured cells and mouse models, as well as experience in molecular biology are desired. Please provide a brief summary of future career plans in your application.

Interested candidates should send curriculum vitae, a brief description of research experience, and names of three references to Dr. Paul Campbell (email: paul.campbell@fccc.edu).

Post-doctoral Position: Moffitt Cancer Center
The Karen Mann lab is recruiting post-doctoral fellows to investigate cooperating cancer drivers that promote pancreatic cancer metastasis. We are focused on delineating transcriptional reprogramming and alternative splicing events influenced by novel drivers identified using Sleeping Beauty insertional mutagenesis in a mouse model of pancreatic cancer. We employ computational, in vitro and novel in vivo approaches to delineate the biological context in which these drivers function. Our lab is in the Department of Molecular Oncology and is part of the Cancer Biology and Evolution Program at Moffitt Cancer Center.

The ideal candidate has a PhD in Genetics, Molecular Biology, Biochemistry or related discipline earned within the last 2 years, a strong foundation in molecular biology, mammalian cell culture and mouse genetics, a proven track record of publication in international journals, and excellent written and oral communication skills.

Interested applicants should send a single PDF file that includes a current CV with recent publications, a personal statement of scientific interests and goals (2-page maximum) including contact information for three references to Dr. Karen Mann via email to Karen.Mann@moffitt.org.

Postdoctoral Position: Institute of Cancer Genetics of Columbia University
A post-doctoral position is available in the lab of Dr. Christine Chio at the Institute of Cancer Genetics of Columbia University to study the etiology and progression of pancreatic ductal adenocarcinoma using ex-vivo organoid cultures and in vivo genetically engineered mouse models. The research interest of the lab is in investigating the role of reactive oxygen species as selective secondary messengers to support cancer cell viability and tumor-stroma co-evolution.

Wage Hope With Us

Join us to double pancreatic cancer survival by 2020.





shop purple logo

Gear, apparel, accessories and more to show off your purple pride.


Shop Now 

©2019 Pancreatic Cancer Action Network. All rights reserved. Terms of Use | Privacy Policy


Pancreatic Cancer Action Network®, PanCAN®, PurpleStride®, Wage Hope®, Know Your Tumor®, Powerful Knowledge. Personal Treatment.®, Precision Promise℠ and Demand Better For Patients. For Survival.℠ are the trademarks of the Pancreatic Cancer Action Network, Inc.


The Pancreatic Cancer Action Network is registered as a 501©3 nonprofit organization. Contributions to the Pancreatic Cancer Action Network are tax-deductible to the extent permitted by law. The Pancreatic Cancer Action Network’s tax identification number is #33-0841281.